Claro Advisors Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1764386 BOSTON, MA

Position in VRTX

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$717,774

+$631 QoQ

Shares Held

1,445

-10.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#952

of 1,735 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Claro Advisors Inc. holds $2,341,182 across 7 Biotechnology names. VRTX ranks #1 (30.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,445	$717,774
2	INCY	Incyte Corp	4,212	$477,472
3	EXEL	Exelixis, Inc.	8,164	$444,203
4	REGN	Regeneron Pharmaceuticals, Inc.	502	$313,017
5	HALO	Halozyme Therapeutics, Inc.	3,407	$266,665
6	AGEN	Agenus Inc	33,350	$102,051
7	AUTL	Autolus Therapeutics plc	12,500	$20,000

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$717,774	1,445	-10.0%	Shares	Sole	2026-07-30
2026-03-31	$717,143	1,606	-5.8%	Shares	Sole	2026-04-21
2025-12-31	$772,978	1,705	-0.8%	Shares	Sole	2026-02-17
2025-09-30	$672,837	1,718	-32.5%	Shares	Sole	2025-11-12
2025-06-30	$1,133,479	2,546	-13.3%	Shares	Sole	2025-08-05
2025-03-31	$1,424,401	2,938	-4.5%	Shares	Sole	2025-05-12
2024-12-31	$1,238,302	3,075	+26.8%	Shares	Sole	2025-01-13
2024-09-30	$1,127,819	2,425	+24.1%	Shares	Sole	2024-11-07
2024-06-30	$915,878	1,954	+43.4%	Shares	Sole	2024-07-31
2024-03-31	$569,747	1,363	+7.7%	Shares	Sole	2024-04-18
2023-12-31	$514,715	1,265	+4.6%	Shares	Sole	2024-01-22
2023-09-30	$420,417	1,209	+13.4%	Shares	Sole	2023-10-10
2023-06-30	$375,136	1,066	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.